Delivery Order SPE2DB20D3505-SPE2DB25FU4V6
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,208.91 and a period of performance through June 6, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award, SPE2DB20D2104|SPE2DB25FMPQL, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which is not a set-aside contract, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has a ceiling value of $3,315.02 and a period of performance ending on April 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML. The $1,268.04 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 12, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML medication. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,594.64 and a performance period ending on May 27, 2025. The award is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,296.60, is a delivery order for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML. The contract has a firm fixed price pricing type and an ultimate completion date of April 14, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any set-aside designation for this...
- This federal contract award, valued at $1,996.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 17, 2025. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,589.59, is a Delivery Order contract with a Firm Fixed Price pricing type. The award covers the procurement of NOVOLOG 100 UNIT/ML VIAL 10ML medical supplies, with an ultimate completion date of February 28, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award and...
- This federal contract award, SPE2DB20D2002|SPE2DB25FL11G, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,028.01, is a Delivery Order on a Firm Fixed Price basis to provide NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a type of medication. The award has a ceiling value of $1,944.90 and a period of performance through February 27, 2025. This appears to be a delivery order contract, with a firm fixed-price pricing type. The contract was not designated with a set-aside requirement, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,944.90 firm fixed-price delivery order is for NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of July 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FU4V6Delivery Order
This federal contract award, SPE2DB20D3505|SPE2DB25FU4V6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,995.33 and a performance period ending on April 28, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not set-aside. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, that provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract award allows Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 4/25/25 |